BioSpace News Archive

Quanterix’ technology to be used in multiplex diagnostic test for cervical disease detection

Senseonics Holdings, Inc. today announced that Aetna, the third largest commercial health plan provider in the United States, is providing coverage for Eversense, effective immediately.

Grupo LALA, S.A.B. de C.V. today reported results for the third quarter 2018. The following information has been presented based on International Financial Reporting Standards (IFRS) and in nominal terms.

Symbility Solutions Inc. and CoreLogic, Inc. today announced the execution of an arrangement agreement (the “Agreement”) pursuant to which CoreLogic has agreed to acquire Symbility Solutions.

In U-ACHIEVE, upadacitinib (15/30/45 mg, once daily) met the primary endpoint of clinical remission (per Adapted Mayo Score) and all ranked secondary endpoints, including endoscopic improvement, clinical remission (per Full Mayo Score) and clinical response, in patients with moderately to severely active ulcerative colitis[1]

EKF Diagnostics, the global in vitro diagnostics company, announces that on Stand C70 in Hall 3 of MEDICA 2018, it will be launching its new Lactate Scout 4 hand-held lactate analyzer for fast and accurate sports performance monitoring.

Endologix, Inc. today announced that it will report financial results for the third quarter of fiscal year 2018 after the market close on Thursday, November 1, 2018.

GlyTR Therapeutics, Inc. is pleased to announce it has been awarded an approximately $300,000 grant from The National Cancer Institute (NCI), National Institute of Health (NIH) thru the Small Business Technology Transfer Program.

BGI Americas, a genomics services leader, and Gencove, a leading genomics technology company, announced today that they have entered into an agreement to offer a new low-pass sequencing service to lower barriers to large-scale genomics projects.

Conference Call and Webcast to Follow